HealthSpace Data Systems promises to deliver its platform for contact tracing within 48 hours to any North American jurisdiction fighting COVID-19 outbreaks.

The rush to collect and measure medically relevant data   Read More

COVID-19 has had a mixed impact on Procter & Gamble’s business. Despite this, the company reported higher earnings in its latest quarter and increased its dividend.

There’s an old saying: “What   Read More

Capital Group Global Equity fund has been a stellar fund over the years. But it’s not resting on its laurels. The fund is adjusting its portfolio in response to the   Read More

The COVID-19 pandemic has increased demand for groceries and other essentials. Loblaw same-store sales are expected to benefit from this demand.

Grocery companies have offered investors shelter in turbulent markets. A   Read More

Seasonality analyst names this conservative ETF, with a basket of diversified international healthcare stocks (which, he says, trumps all other market sectors), as his current ‘best buy’.

Market volatility will be   Read More

Laurentian analyst predicts that after a difficult 2019, troubled marijuana stocks will find their redemption, particularly his “preferred pick” selection, Aurora Cannabis Inc.

Turnaround stories often coincide with the start of   Read More

With the slow rollout of cannabis stores in Ontario, pot stocks have been beaten down. But that has made some of them more attractively valued.

After initially getting upset at Aphria   Read More

Oil and gas exploration and the emergence of a new coronavirus make for strange bedfellows in Contra the Heard’s Benj Gallander’s choice of his two current best buys.
While stock markets   Read More

Healthcare stock Extendicare operates over 120 long-term care and retirement home facilities across Canada and runs its home care business through 35 branches across the country.

Healthcare stock Extendicare Inc. (TSX—EXE)   Read More

With the slow rollout of cannabis stores in Ontario, pot stocks have been beaten down. But that has made some of them more attractively valued.

After initially getting upset at Aphria   Read More

Laurentian analyst predicts that after a difficult 2019, troubled marijuana stocks will find their redemption, particularly his “preferred pick” selection, Aurora Cannabis Inc.

Turnaround stories often coincide with the start of   Read More

Curaleaf is one of the largest vertically-integrated cannabis companies in the US. Organic vertical integration is a key strategy.

Curaleaf Holdings Inc. (CNSX—CURA) reports record numbers (not uncommon for fledgling marijuana   Read More

Earnings outlooks for 2020 have set the prices of manufacturing stocks AG Growth International and Medtronic plc.
The shares of manufacturing stock AG Growth International (TSX—AFN) fell substantially in August, giving   Read More

We’ve added Mackenzie Canadian Growth Fund to our Recommended Mutual Funds list.
Mackenzie Canadian Growth Fund (Fund codes: MFC650(FE), MFC640(BE), MFC7028(LL)) invests mainly in Canadian stocks to achieve long-term capital growth   Read More

Jamieson Wellness manufactures branded natural health products including vitamins, minerals, and supplements. CIBC World Markets says it’s an “outperformer”.

Hoping to inject health into your bank account too, Toronto-based CIBC World   Read More

Given that we consider the Canadian dollar to be undervalued in relation to the US dollar, we generally recommend you hedge your currency risk when investing south of the border.

Despite   Read More

Portfolio manager and financial analyst John Kim picks two US blue chip stocks as his current ‘best buys’: CVS Health Corp. and AT&T Inc.
Caution is the name of the game   Read More

A recent survey by The MoneyLetter of securities analysts’ reports found two junior cannabis-related stocks favored by Toronto-based Mackie Research Capital.
Toronto-based Mackie Research analyst Nikhil Thadani initiated coverage of technology   Read More

Healthcare stock Abacus Health Products develops and commercializes over-the-counter topical pain relief and therapeutic skincare products.
Abacus Health Products Inc. (CNSX—ABCS) is poised to become a leader in the topical pain   Read More

While drugs and gold were the two most popular forms of payment for votes in the recent election in India, portfolio manager Elvis Picardo proffers far better reasons for picking   Read More

While drugs and gold were the two most popular forms of payment for votes in the recent election in India, portfolio manager Elvis Picardo proffers far better reasons for picking   Read More

“Being able to perform in line or better than the market while holding almost a third in cash suggests that our stock picking and trading strategy have provided positive alpha   Read More

Consumer goods stock Johnson & Johnson faces a public relations nightmare that could cost it billions. From a purely financial viewpoint, however, this global stock remains a buy.
US stock Johnson   Read More

Analyst Alp Erdogan says that in 2019, capital that bloated the 2018 prices of cryptocurrencies, cannabis stocks and blockchain technology generally will shift toward value stocks with better defensive characteristics.   Read More

We’ve added a new fund to our recommended Conservative Canadian Stock Funds on the Money Reporter’s ‘The Top 40: Canada’s Best Mutual Funds’ list. Mackenzie Canadian Growth Fund’s investment approach   Read More

Canntab Therapeutics Inc. has developed a process to incorporate cannabis extracts into pills that administer measured, standardized dosages, and include a unique delivery system to enable time-controlled absorption. Investor’s Digest   Read More

Open Text has improved the quality of its revenues by increasing the amount of recurring revenues it earns. Higher-quality revenues should help it to continue to deliver the cash flows   Read More

Vancouver-based PI Financial Corp. analysts Bob Gibson, Jason Zandberg and Devin Schilling recently teamed up to review their most recent list of ‘top stock picks’ for Investor’s Digest of Canada.   Read More

We’ve added a new fund to our recommended Conservative Canadian Stock Funds on the Money Reporter’s ‘The Top 40: Canada’s Best Mutual Funds’ list. Mackenzie Canadian Growth Fund’s investment approach   Read More

Investor’s Digest of Canada contributors Doug Cooper and David Kideckel, Toronto-based Beacon Securities equity analysts, argue the United States is in the midst of a pot revolution. Americans are hankering   Read More

A junior marijuana start-up has just closed a deal to buy an enormous former food plant facility in Cobourg, Ontario, that spans 27 acres and once manufactured cereals, dog food,   Read More

‘Where there’s smoke, there’s . . . opportunity’ concludes The MoneyLetter after surveying a number of security analysts’ reports on medical cannabis producers in Canada. Companies already established in the   Read More

Cardinal Health’s problems with Cordis, plus the negative impact of generic drug pricing on company profits, has given us pause on this healthcare stock. We recommend that purchases be deferred   Read More

A mouse trap it isn’t, but the world’s Holter monitor wearers may want to beat a path to the door of medical technology stock iRhythm Technologies Inc., a digital health   Read More

A number of established medical marijuana producers are preparing themselves for expansion and entry into the soon-to-be-legal recreational marijuana market. The MoneyLetter recently surveyed a number of security analysts’ reports   Read More

PI Financial analysts Devin Schilling and Jason Zandberg are ‘fired up’ about a new supplier of medical cannabis, whose mission, in turn, is to ‘light up’ the cannabis sector.
BC-based   Read More

With the rapid rise of US stock prices these past several years, it has become increasingly difficult to find reasonably valued stocks in the US market. Here are three stocks   Read More

Investor’s Digest recently reported on Calgary-based Acumen Capital analysts Brian Pow, Nick Corcoran and Ted Bobier’s five favourite growth stock candidates for 2018.
Early trading in 2018 showed strong market   Read More

It’s best to diversify your portfolio across all five sectors of the economy: finance, utilities, consumer, manufacturing and resources. Remember, though, there’s danger in loading up on stocks in sectors   Read More

We expect consumer stock Walgreens Boots Alliance to deliver long-term share price gains. We also expect this ‘dividend aristocrat’ to continue to raise its dividend each year. And we further   Read More

Many financial analysts will argue that medical marijuana producers are bargain stocks today. But one such bargain stock that Mackie Research analyst Greg McLeish recommends is a bargain that he   Read More

Many financial analysts will argue that medical marijuana producers are bargain stocks today. But one such bargain stock that Mackie Research analyst Greg McLeish recommends is a bargain that he   Read More

Seniors housing and business software technology may make for an odd couple on anybody’s ‘best of anything’ list. But chartered financial analyst Christine Poole sees money to be made from   Read More

Blue-chip consumer goods stock Metro Inc. has agreed to acquire drugstore chain Jean Coutu Group. We think that Metro will profit from this transaction. It remains a buy. Coutu’s shares   Read More

Four times a year The Investment Reporter reviews its outlook for the economy’s five main sectors—financial, utilities, manufacturing, consumer and resources. Its guiding rule is that investors keep at least   Read More

US stock Cardinal Health did well in the year to June 30. This year it’s expected to struggle. But the shares are cheap for a blue chip stock that rewards   Read More

Beacon Securities head of research, Toronto-based Doug Cooper, analyzed New Look Vision Group’s latest acquisition and concluded that the transaction not only grows New Look’s store count by about 66   Read More

‘Le jour de gloire est arrivé,’ according to Equium Capital Management president Cameron Hurst. Mr. Hurst sees more stability in Germany and riskier opportunities in Italy and Spain, but he   Read More

Cyclical investing works if the timing is right. The key question is: “Is this the right time?” Our current expansion (begun in 2009) is getting long in the tooth. Sectors   Read More

The S&P/TSX hasn’t shared in the current strength of global stock markets. In fact, the Toronto market has lost ground since it reached an all-time high in February. Only a   Read More

Portfolio manager Lorne Zeiler picks a US-based global healthcare stock and a Canadian preferred share exchange traded fund as his current two ‘best buys’ for investors seeking high dividend income   Read More

Hero today, Zero tomorrow. That’s how ValueTrend portfolio manager Keith Richards reminds himself that sector rotation is becoming faster and more pronounced of late. So who’s hot, and who’s not?   Read More